← back to database
Pfizer Ventures is Pfizer’s strategic corporate venture arm. It invests globally from Seed through IPO, with a strong emphasis on early-stage biopharmaceutical companies developing transformative therapeutics and platform technologies in Pfizer’s core disease areas. Typical initial investments are $5 million–$20 million, and the team can lead or join syndicates.
Stage focus
Lead / follow
Check size
Specialization
Generalist / Specialist
Specialist
Latest fund size
$600 million additional commitment announced in 2018
Latest fund vintage
2018
Investing team
Anthony BarryPartner
- Christopher O'DonnellPartner
Irena MelnikovaPartner
Marie-Claire PeakmanPartner
Michael C. DiemSenior Managing Partner
Rana Al-HallaqPartner
How to reach them
https://www.pfizer.com/about/partners/submit-your-opportunities